Overview
CCEL market data
Price History
CCEL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.30 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.52 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1,556.3% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.72 – $5.43 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $28.5 · P/B 25.24 · P/S 0.91.
Company news
Cryo-Cell International Q2 EPS $0.07 Up From $0.04 YoY, Sales $7.800M Down From $7.900M YoYBenzinga · Jul 15, 2026, 8:31 PM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Jun 26, 2026, 5:10 PM
8-K filing — CRYO CELL INTERNATIONAL INC (CCEL)SEC EDGAR · May 8, 2026, 8:00 PM